HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia.

Abstract
Alzheimer's disease and other tauopathies are characterized by the presence of intracellular neurofibrillary tangles composed of hyperphosphorylated, insoluble tau. General anesthesia has been shown to be associated with increased risk of Alzheimer's disease, and we have previously demonstrated that anesthesia induces hypothermia, which leads to overt tau hyperphosphorylation in the brain of mice regardless of the anesthetic used. To investigate whether anesthesia enhances the long-term risk of developing pathological forms of tau, we exposed a mouse model with tauopathy to anesthesia and monitored the outcome at two time points-during anesthesia, or 1 wk after exposure. We found that exposure to isoflurane at clinically relevant doses led to increased levels of phospho-tau, increased insoluble, aggregated forms of tau, and detachment of tau from microtubules. Furthermore, levels of phospho-tau distributed in the neuropil, as well as in cell bodies increased. Interestingly, the level of insoluble tau was increased 1 wk following anesthesia, suggesting that anesthesia precipitates changes in the brain that provoke the later development of tauopathy. Overall, our results suggest that anesthesia-induced hypothermia could lead to an acceleration of tau pathology in vivo that could have significant clinical implications for patients with early stage, or overt neurofibrillary tangle pathology.
AuthorsEmmanuel Planel, Alexis Bretteville, Li Liu, Laszlo Virag, Angela L Du, Wai Haung Yu, Dennis W Dickson, Robert A Whittington, Karen E Duff
JournalFASEB journal : official publication of the Federation of American Societies for Experimental Biology (FASEB J) Vol. 23 Issue 8 Pg. 2595-604 (Aug 2009) ISSN: 1530-6860 [Electronic] United States
PMID19279139 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Anesthetics, Inhalation
  • tau Proteins
  • Isoflurane
  • Glycogen Synthase Kinase 3 beta
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Glycogen Synthase Kinase 3
Topics
  • Alzheimer Disease (etiology)
  • Anesthesia, Inhalation (adverse effects)
  • Anesthetics, Inhalation (toxicity)
  • Animals
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 (metabolism)
  • Disease Models, Animal
  • Female
  • Glycogen Synthase Kinase 3 (metabolism)
  • Glycogen Synthase Kinase 3 beta
  • Humans
  • Isoflurane (toxicity)
  • Male
  • Mice
  • Mice, Mutant Strains
  • Microtubules (metabolism, pathology)
  • Motor Skills
  • Neurofibrillary Tangles (metabolism, pathology)
  • Phosphorylation
  • Spinal Cord (metabolism, pathology)
  • Tauopathies (etiology, genetics, metabolism, pathology)
  • tau Proteins (chemistry, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: